What is the official website of WIRX Pharmacy ?

The official website of WIRX Pharmacy is http://www.wirxpharmacy.com.

What is WIRX Pharmacy's cybersecurity risk score?

WIRX Pharmacy has an AI-generated cybersecurity risk score of 687 out of 1000, indicating a Weak security posture according to Rankiteo's assessment.

How many security incidents has WIRX Pharmacy experienced?

According to Rankiteo, WIRX Pharmacy currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has WIRX Pharmacy been affected by any supply chain cyber incidents ?

According to Rankiteo, WIRX Pharmacy has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does WIRX Pharmacy have SOC 2 Type 1 certification ?

According to Rankiteo, WIRX Pharmacy is not certified under SOC 2 Type 1.

Does WIRX Pharmacy have SOC 2 Type 2 certification ?

According to Rankiteo, WIRX Pharmacy does not hold a SOC 2 Type 2 certification.

Does WIRX Pharmacy comply with GDPR ?

According to Rankiteo, WIRX Pharmacy is not listed as GDPR compliant.

Does WIRX Pharmacy have PCI DSS certification ?

According to Rankiteo, WIRX Pharmacy does not currently maintain PCI DSS compliance.

Does WIRX Pharmacy comply with HIPAA ?

According to Rankiteo, WIRX Pharmacy is not compliant with HIPAA regulations.

Does WIRX Pharmacy have ISO 27001 certification ?

According to Rankiteo,WIRX Pharmacy is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does WIRX Pharmacy operate in ?

WIRX Pharmacy operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does WIRX Pharmacy have ?

WIRX Pharmacy employs approximately 16 people worldwide.

Does WIRX Pharmacy own any subsidiaries ?

WIRX Pharmacy presently has no subsidiaries across any sectors.

How many LinkedIn followers does WIRX Pharmacy have ?

WIRX Pharmacy's official LinkedIn profile has approximately 1,798 followers.

What is the NAICS classification code for WIRX Pharmacy ?

WIRX Pharmacy is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does WIRX Pharmacy have a Crunchbase profile ?

No, WIRX Pharmacy does not have a profile on Crunchbase.

Does WIRX Pharmacy have a LinkedIn profile ?

Yes, WIRX Pharmacy maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/wirxpharmacy.

How many cybersecurity incidents has WIRX Pharmacy experienced ?

As of October 21, 2026, Rankiteo reports that WIRX Pharmacy has experienced 1 cybersecurity incidents.

How many peer or competitor companies does WIRX Pharmacy have ?

WIRX Pharmacy has an estimated 5,778 peer or competitor companies worldwide.

What types of cybersecurity incidents has WIRX Pharmacy faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

WIRX Pharmacy

Boost Score +25 with badge (5 left)

687

/1000

Weak

712

/1000

Moderate

WIRX Pharmacy Vendor Cyber Rating & Cyber Score

wirxpharmacy.com

Add Your Compliance Badge

WIRX Pharmacy is a rapidly growing home-delivery pharmacy serving injured workers. The vision for WIRX is and always has been making your life easier. As an independent pharmacy, we work incessantly to help our clients in any way we can. That means service you can count on when you need it most. Unlike a retail or mail-order pharmacy, we guarantee that your client’s medication will be at their front door within 24-48 hours with NO out-of-pocket costs! Call to register today at: 877-882-WIRX As a patient-centric worker's compensation pharmacy we’ve made it our duty to ensure pharmaceuticals are available to alleviate the suffering of the injured person as quickly as possible by offering an industry leading private delivery option. Our

WIRX Pharmacy

WIRX Pharmacy CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

WIRX Pharmacy

Breach

12/2025

WIR1771015318

Loading…

A.I.

WIRX Pharmacy Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for WIRX Pharmacy

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for WIRX Pharmacy in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for WIRX Pharmacy in 2026.

Incident Types WIRX Pharmacy vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for WIRX Pharmacy in 2026.

Incident History - WIRX Pharmacy (X = Date, Y = Severity)

Loading…

SUBSIDIARY

WIRX Pharmacy Subsidiaries

WIRX Pharmacy

Pharmaceutical Manufacturing

Website: http://www.wirxpharmacy.com

Company Size: 11-50 employees

WIRX Pharmacy value to injured workers!Pharmaceutical Manufacturing

Loading…

WIRX Pharmacy Similar Companies

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Alkem Laboratories Ltd.

alkemlabs.com

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

MENARINI Group

menarini.com

The Menarini Group is a leading international pharmaceutical and diagnostics company, with 140 years of history, present in 140 countries worldwide, with a turnover of 4.88 billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants and is distributed across six continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

PT Kalbe Farma, Tbk

kalbe.co.id

Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching to international markets to transform itself into an integrated consumer health and nutrition enterprise to promote its mission to improve health for a better life. Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: the Prescription Pharmaceutical Division, Consumer Health Division, Nutritionals Division and Distribution and Logistics Division. These business divisions manage an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drink and nutrition products, as well as a robust distribution arm serving over one million outlets across Indonesia’s vast archipelago. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market. Kalbe Farma has established a robust research and development activities in leading edge generic drug formulation and continuous development of innovative consumer and nutritional products. Through strategic alliances with international partners, Kalbe have also started to support several successful research and development venture working on cancer drugs, stem cells and biotechnology research. With 17,000 employees, Kalbe Farma is the largest healthcare provider in Indonesia, with unrivaled marketing, branding, distribution, financial strength and research and development expertise. Kalbe Farma is also the largest publicly-listed pharmaceutical company in Southeast Asia, commanding a market capitalization of Rp71.0 trillion and sales turnover Rp21.0 trillion by end of 2018.

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

Novartis

novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Loading…

NEWS

WIRX Pharmacy CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

February 20, 2026 08:00 AM

WIRX Pharmacy Data Breach Claims Investigated by Lynch Carpenter

PITTSBURGH, Feb. 20, 2026 (GLOBE NEWSWIRE) -- WIRX Pharmacy (“WIRX”), a pharmacy provider serving patients with workers' compensation claims...

Read Article

February 13, 2026 08:00 AM

WIRX Pharmacy Data Breach Investigation

Strauss Borrelli PLLC, a leading data breach law firm, is investigating WIRX Pharmacy (“WIRX”) regarding its recent data breach.

Read Article

July 14, 2025 07:00 AM

Dordt University Data Breach Lawsuit Investigation

Did Dordt send you a data breach letter? If so, your personal info may have been exposed, and you could now help start a class action.

Read Article

October 31, 2024 07:00 AM

Stryker Corporation Data Breach Lawsuit Investigation

Got a letter about the Stryker data breach? You may be able to start a class action to recover money for exposure of your information.

Read Article

October 03, 2024 07:00 AM

American Water Data Breach Lawsuit Investigation

If you are a customer of the company, you may be able to start a class action to collect money for any harm resulting from the cybersecurity...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-113705

SUMMARY

A vulnerability was determined in a2aproject a2a-rs up to 0.4.3. This issue affects some unknown processing of the file a2a-server/src/error.rs. Executing a manipulation can lead to information exposure through error message. The attack can be executed remotely. This patch is called 713b943af94ab2d521d483b841618b97a2e78a4d. A patch should be applied to remediate this issue.

Published

Date2026-10-20

Updated

Date2026-10-20

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-9825

SUMMARY

IBM Cyber Fraud 1.0.0 through 1.0.2 has a missing secure attribute allowing sensitive cookies to be transmitted over unencrypted connections, potentially enabling an attacker to intercept session data through network-based attacks.

Published

Date2026-10-20

Updated

Date2026-10-20

RISK INFORMATION (Score: 3.7)

cvss3

Base Score: 3.7

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:N/A:N

Impact Score

1.4

Exploitability

2.2

REFERENCES

https://www.ibm.com/support/pages/node/7290671

CVE-2026-94402

SUMMARY

IBM Carbon Charts 0.4.0 through 1.27.19 is vulnerable to cross-site scripting. The MeterChart component's Title.truncateTitle() function re-inserts a substring of user-supplied label text into the DOM via an unsanitized innerHTML write when the title exceeds the available container width. A remote attacker could exploit this vulnerability to execute arbitrary JavaScript in the victim's browser session.

Published

Date2026-10-20

Updated

Date2026-10-20

RISK INFORMATION (Score: 6.1)

cvss3

Base Score: 6.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Impact Score

2.7

Exploitability

2.8

REFERENCES

https://www.ibm.com/support/pages/node/7291785

CVE-2026-93888

SUMMARY

IBM Sterling Connect Direct for Unix 6.4.0.0 through 6.4.0.6 and 6.3.0.0 through 6.3.0.7 apnotify utility is vulnerable to a code injection due to insufficient validation of user input.

Published

Date2026-10-20

Updated

Date2026-10-20

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

https://www.ibm.com/support/pages/node/7292127

CVE-2026-93744

SUMMARY

IBM i 7.3, 7.4, 7.5, and 7.6 could allow an unathenticated remote attacker to bypass security restrictions due to improper access control. By sending a specially crafted HTTP request to any URL within the Navigator application prior to authentication, a bad actor could exploit this vulnerability to alter server-side session security state.

Published

Date2026-10-20

Updated

Date2026-10-20

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N

Impact Score

2.5

Exploitability

3.9

REFERENCES

https://www.ibm.com/support/pages/node/7292223

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

WIRX Pharmacy Vendor Cyber Rating & Cyber Score

WIRX Pharmacy A.I CyberSecurity Scoring

WIRX Pharmacy CyberSecurity News & History

WIRX Pharmacy Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for WIRX Pharmacy

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types WIRX Pharmacy vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - WIRX Pharmacy (X = Date, Y = Severity)

WIRX Pharmacy Subsidiaries

WIRX Pharmacy

WIRX Pharmacy Similar Companies

Lupin

Sandoz

Alkem Laboratories Ltd.

MENARINI Group

Grifols

PT Kalbe Farma, Tbk

Zydus Group

Catalent

Novartis

WIRX Pharmacy CyberSecurity News

WIRX Pharmacy Data Breach Claims Investigated by Lynch Carpenter

WIRX Pharmacy Data Breach Investigation

Dordt University Data Breach Lawsuit Investigation

Stryker Corporation Data Breach Lawsuit Investigation

American Water Data Breach Lawsuit Investigation

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

WIRX Pharmacy CyberSecurity News & History

WIRX Pharmacy Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for WIRX Pharmacy

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types WIRX Pharmacy vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - WIRX Pharmacy (X = Date, Y = Severity)

WIRX Pharmacy Subsidiaries

WIRX Pharmacy

WIRX Pharmacy Similar Companies

Lupin

Sandoz

Alkem Laboratories Ltd.

MENARINI Group

Grifols

PT Kalbe Farma, Tbk

Zydus Group

Catalent

Novartis

WIRX Pharmacy CyberSecurity News

WIRX Pharmacy Data Breach Claims Investigated by Lynch Carpenter

WIRX Pharmacy Data Breach Investigation

Dordt University Data Breach Lawsuit Investigation

Stryker Corporation Data Breach Lawsuit Investigation

American Water Data Breach Lawsuit Investigation

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo